Cytokinetics Receives Revised Rating from UBS Analyst Downgraded to Neutral with Raised Price Target
On January 24, 2024, Cytokinetics (NASDAQ: CYTK) received a revised rating from UBS analyst Ashwani Verma. Verma downgraded the stock...
On January 24, 2024, Cytokinetics (NASDAQ: CYTK) received a revised rating from UBS analyst Ashwani Verma. Verma downgraded the stock...
On January 24, 2024, Johnson & Johnson (JNJ) released its impressive financial results for the fourth quarter of 2023. The...
On January 24, 2024, SciSparc Ltd. announced a significant milestone in its growth strategy by entering into a standby equity...
On January 24, 2024, Otavio Tanganelli, an analyst at Banco Bradesco BBI S.A, made a noteworthy move by upgrading StoneCo...
On January 24, 2024, United Community Banks (NASDAQ: UCBI) announced their quarterly earnings, exceeding expectations with earnings of $0.53 per...
Bitfarms Ltd., a renowned Bitcoin mining company operating worldwide, has recently made a significant stride towards expanding its mining capabilities....
On January 24, 2024, Mobilicom's groundbreaking ICE Cybersecurity took center stage as it was chosen by Israel's Ministry of Defense...
On January 24, 2024, MAIA Biotechnology proudly announced the release of their groundbreaking international Patent Cooperation Treaty (PCT) patent application....
On January 24, 2024, an exciting collaboration was announced between Lockheed Martin and Red 6. This strategic joint venture and...
Insider selling of company shares can offer valuable insights into the state of a company and its prospects. However, it...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com